| Financial Year |
March 31 2023 |
| Monetary Funds |
151,415,980.54 |
| Held-for-trading Financial Assets |
930,335,587.45 |
| Notes Receivable |
96,393,217.74 |
| Accounts Receivable |
750,378,014.26 |
| Advances to Suppliers |
6,665,847.00 |
| Other Receivables |
29,436,436.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
156,195,823.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,360,624.21 |
| Total Current Assets |
2,616,889,156.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
395,610,829.62 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
72,223,635.07 |
| R&D expenses |
-- |
| Goodwill |
151,103,909.60 |
| Long-Term Deferred and Prepaid Expenses |
4,969,467.08 |
| Deferred Income Tax Assets |
43,348,491.39 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,089,312,917.10 |
| Total Assets |
3,706,202,073.20 |
| Short-Term Loans |
29,599,408.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,509,161.80 |
| Accounts Payable |
249,089,990.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
53,863,053.60 |
| Taxes Payable |
63,590,566.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
54,226,537.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
408,426.01 |
| Other Current Liabilities |
84,358,502.47 |
| Sub-Total of Current Liabilities |
563,271,951.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
25,783,942.16 |
| Deferred Income Tax Liabilities |
706,582.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
27,372,912.97 |
| Total Liabilities |
590,644,864.05 |
| Paid-In Capital(Or Share Stock) |
779,829,726.00 |
| Capital Surplus |
334,726,118.92 |
| Surplus Reserve |
204,207,542.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,597,287,855.05 |
| Minority Stockholder's Interest |
266,804,497.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,848,752,711.73 |
| Owner's Equity（Stockholder's Equity） |
3,115,557,209.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,706,202,073.20 |
